Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiyuki Miura

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Kidney International|November 1, 2013
Awaiting the OSCAR subanalysis of subjects according to the presence of proteinuriaMichio Fukuda, Toshiyuki Miura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 24, 2016
Need for public awareness regarding low birth weight and bottle feedingToshiyuki Miura, Michio Fukuda, Masashi Mizuno, et al.
Pharmacoepidemiology and Drug Safety|March 5, 2014
Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in JapanTomoko Kurita, Tomomi Kitaichi, Takako Nagao, et al.
IAVI Report : Newsletter on International AIDS Vaccine Research|March 10, 2010
HIV controllersToshiyuki Miura, Kholiswa Ngumbela, Danni Ramduth, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|May 17, 2014
The natriuretic effect of angiotensin receptor blockers is not attributable to blood pressure reduction during the previous night, but to inhibition of tubular sodium reabsorptionToshiyuki Miura, Shuichi Watanabe, Maki Urushihara, et al.
Emerging Infectious Diseases|March 12, 2011
Human infection with Pseudoterranova azarasi roundwormNaoki Arizono, Toshiyuki Miura, Minoru Yamada, et al.
Parasitology International|April 10, 2012
Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research groupMikio Kimura, Michiko Koga, Tadashi Kikuchi, et al.
Pharmacoepidemiology and Drug Safety|March 4, 2014
Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in JapanTomoko Kurita, Tomomi Kitaichi, Takako Nagao, et al.
Current Medical Research and Opinion|December 4, 2019
Safety analysis of Lexiva tablets 700 (fosamprenavir calcium hydrate) in post-marketing surveillance in JapanAkiko Fukuda, Takako Nagao, Tomomi Kitaichi, et al.
Parasitology International|July 16, 2013
Efficacy and safety of paromomycin for treating amebiasis in JapanTadashi Kikuchi, Michiko Koga, Shoichi Shimizu, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Kidney International|November 1, 2013
Awaiting the OSCAR subanalysis of subjects according to the presence of proteinuriaMichio Fukuda, Toshiyuki Miura
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 24, 2016
Need for public awareness regarding low birth weight and bottle feedingToshiyuki Miura, Michio Fukuda, Masashi Mizuno, et al.
Pharmacoepidemiology and Drug Safety|March 5, 2014
Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in JapanTomoko Kurita, Tomomi Kitaichi, Takako Nagao, et al.
IAVI Report : Newsletter on International AIDS Vaccine Research|March 10, 2010
HIV controllersToshiyuki Miura, Kholiswa Ngumbela, Danni Ramduth, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|May 17, 2014
The natriuretic effect of angiotensin receptor blockers is not attributable to blood pressure reduction during the previous night, but to inhibition of tubular sodium reabsorptionToshiyuki Miura, Shuichi Watanabe, Maki Urushihara, et al.
Emerging Infectious Diseases|March 12, 2011
Human infection with Pseudoterranova azarasi roundwormNaoki Arizono, Toshiyuki Miura, Minoru Yamada, et al.
Parasitology International|April 10, 2012
Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research groupMikio Kimura, Michiko Koga, Tadashi Kikuchi, et al.
Pharmacoepidemiology and Drug Safety|March 4, 2014
Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in JapanTomoko Kurita, Tomomi Kitaichi, Takako Nagao, et al.
Current Medical Research and Opinion|December 4, 2019
Safety analysis of Lexiva tablets 700 (fosamprenavir calcium hydrate) in post-marketing surveillance in JapanAkiko Fukuda, Takako Nagao, Tomomi Kitaichi, et al.
Parasitology International|July 16, 2013
Efficacy and safety of paromomycin for treating amebiasis in JapanTadashi Kikuchi, Michiko Koga, Shoichi Shimizu, et al.
Pageof 9